Literature DB >> 24908141

Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.

Li Zhou1, Jing-An Rui, Shao-Bin Wang, Shu-Guang Chen, Qiang Qu.   

Abstract

Many factors associated with long-term outcome in hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) were previously identified. However, those in HCC without PVTT have not been elucidated. This study was designed to define the risk factors of poor post-surgical survival and recurrence in this subgroup of HCC. Medical records and follow-up data of consecutive 152 patients with PVTT-absent HCC underwent curative resection were reviewed. The impacts of clinical and pathological variables on patient survival and recurrence were evaluated by univariate and multivariate analyses. It was shown that Edmondson-Steiner grade, TNM stage, microvascular invasion (MVI), satellite nodule, serum AFP level, tumor size and number were significant for tumor-specific and/or tumor-free survival in univariate analysis. Among them, Edmondson-Steiner grade and TNM stage were of independent significances for both, whereas satellite nodule independently predicted tumor-free survival. In Chi-square test, Edmondson-Steiner grade, TNM stage and MVI were significantly related to overall as well as early recurrence. Stepwise logistic regression identified Edmondson-Steiner grade as the single independent predictor of both. To be summarized, variables that are associated with poor prognosis and recurrence in HCC without PVTT are all tumor-related ones. Of these, differentiation degree might be of particular importance.

Entities:  

Mesh:

Year:  2014        PMID: 24908141     DOI: 10.1007/s12253-014-9798-2

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  40 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Authors:  Sang Min Yoon; Young-Suk Lim; Hyung Jin Won; Jong Hoon Kim; Kang Mo Kim; Han Chu Lee; Young-Hwa Chung; Yung Sang Lee; Sung Gyu Lee; Jin-Hong Park; Dong Jin Suh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-27       Impact factor: 7.038

4.  Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study.

Authors:  Jun Luo; Rong-Ping Guo; Eric C H Lai; Yao-Jun Zhang; Wan Yee Lau; Min-Shan Chen; Ming Shi
Journal:  Ann Surg Oncol       Date:  2010-09-14       Impact factor: 5.344

5.  Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

Authors:  Jae Min Chun; Hyung Jun Kwon; Junho Sohn; Sang Geol Kim; Ji-Young Park; Han Ik Bae; Young Kook Yun; Yoon Jin Hwang
Journal:  J Surg Oncol       Date:  2010-12-22       Impact factor: 3.454

6.  Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Hui-Chuan Sun; Yun-Shan Tan
Journal:  Mol Biol Rep       Date:  2010-11-23       Impact factor: 2.316

7.  Prognosis of hepatocellular carcinoma with portal vein tumor thrombus:assessment based on clinical and computer tomography characteristics.

Authors:  Lizhong Jia; Shigeru Kiryu; Takeyuki Watadani; Hiroyuki Akai; Hideomi Yamashita; Masaaki Akahane; Kuni Ohtomo
Journal:  Acta Med Okayama       Date:  2012       Impact factor: 0.892

8.  Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Yung-Chih Lai; Cheng-Yen Shih; Chin-Ming Jeng; Sien-Sing Yang; Jui-Ting Hu; Yung-Chuan Sung; Han-Ting Liu; Shaw-Min Hou; Chi-Hwa Wu; Tzen-Kwan Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma.

Authors:  T Wang; H S Hu; Y X Feng; J Shi; N Li; W X Guo; J Xue; D Xie; S R Liu; M C Wu; S Q Cheng
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

10.  Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma.

Authors:  Chih H Cheng; Chen F Lee; Tsung H Wu; Kun M Chan; Hong S Chou; Ting J Wu; Ming C Yu; Tse C Chen; Wei C Lee; Miin F Chen
Journal:  World J Surg Oncol       Date:  2011-09-30       Impact factor: 2.754

View more
  9 in total

1.  Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.

Authors:  Yi-Peng Fu; Yong Yi; Jin-Long Huang; Chu-Yu Jing; Jian Sun; Xiao-Chun Ni; Zhu-Feng Lu; Ya Cao; Jian Zhou; Jia Fan; Shuang-Jian Qiu
Journal:  Oncologist       Date:  2017-04-24

2.  Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.

Authors:  T T Zhang; X Q Zhao; Z Liu; Z Y Mao; L Bai
Journal:  Clin Transl Oncol       Date:  2015-11-17       Impact factor: 3.405

3.  Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma: correlation with microvascular invasion and histologic grade.

Authors:  Likun Cao; Jie Chen; Ting Duan; Min Wang; Hanyu Jiang; Yi Wei; Chunchao Xia; Xiaoyue Zhou; Xu Yan; Bin Song
Journal:  Quant Imaging Med Surg       Date:  2019-04

4.  Preoperative evaluation of the histological grade of hepatocellular carcinoma with diffusion-weighted imaging: a meta-analysis.

Authors:  Jie Chen; Mingpeng Wu; Rongbo Liu; Siyi Li; Ronghui Gao; Bin Song
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 5.  New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Authors:  Jun Yin; Wen-Tao Bo; Jian Sun; Xiao Xiang; Jin-Yi Lang; Jian-Hong Zhong; Le-Qun Li
Journal:  J Clin Transl Hepatol       Date:  2017-03-30

6.  Postoperative adjuvant TACE-associated nomogram for predicting the prognosis of resectable Hepatocellular Carcinoma with portal vein Tumor Thrombus after Liver Resection.

Authors:  Fuchen Liu; Xinggang Guo; Wei Dong; Wenli Zhang; Shuxun Wei; Shutong Zhang; Xiuli Zhu; Weiping Zhou; Jinmin Zhang; Hui Liu
Journal:  Int J Biol Sci       Date:  2020-10-23       Impact factor: 6.580

7.  Protein kinase N1 promotes proliferation and invasion of liver cancer.

Authors:  Xia Wang; Yansong Ge; Mingqi Shi; Hanhan Dai; Wei Liu; Peiyuan Wang
Journal:  Exp Ther Med       Date:  2021-04-19       Impact factor: 2.447

Review 8.  Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges.

Authors:  Jin-Fang Jiang; Yong-Cong Lao; Bao-Hong Yuan; Jun Yin; Xin Liu; Long Chen; Jian-Hong Zhong
Journal:  Oncotarget       Date:  2017-05-16

9.  Radiomics Analysis of Contrast-Enhanced CT for Hepatocellular Carcinoma Grading.

Authors:  Wen Chen; Tao Zhang; Lin Xu; Liang Zhao; Huan Liu; Liang Rui Gu; Dai Zhong Wang; Ming Zhang
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.